MedPath

Russian Academy of Medical Sciences

🇷🇺Russia
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

35

Active:0
Completed:17

Trial Phases

5 Phases

Phase 1:5
Phase 2:8
Phase 3:1
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (31 trials with phase data)• Click on a phase to view related trials

Not Applicable
12 (38.7%)
Phase 2
8 (25.8%)
Phase 1
5 (16.1%)
Phase 4
5 (16.1%)
Phase 3
1 (3.2%)

MelPRO-0322 (CRISTINA Trial) [miCrobiome pRedIctS aPD1 effecTivnes In melaNoma pAtietns]

Recruiting
Conditions
Melanoma Stage Iii
Melanoma, Skin
First Posted Date
2024-03-08
Last Posted Date
2024-03-08
Lead Sponsor
Russian Academy of Medical Sciences
Target Recruit Count
72
Registration Number
NCT06299878
Locations
🇷🇺

N.N. Blokhin Russian Cancer Research Center, skin tumor department, Moscow, Russian Federation

Intranasal Inhalations of M2 Macrophage Soluble Factors in Children With Developmental Speech Disorders

Phase 1
Completed
Conditions
Language; Developmental Disorder, Receptive
Speech Disorders in Children
Attention Deficit-Hyperactivity Disorder
Language Delay
Language; Developmental Disorder, Expressive
Autism Spectrum Disorder
First Posted Date
2020-12-30
Last Posted Date
2022-05-02
Lead Sponsor
Russian Academy of Medical Sciences
Target Recruit Count
14
Registration Number
NCT04689282
Locations
🇷🇺

Institute of Fundamental and Clinical Immunology, Novosibirsk, Russian Federation

Atypical MOLes and Melanoma Early Detection Study (MoleMed)

Not Applicable
Conditions
Melanoma (Skin)
Moles
Nevus
Nevus, Spitz
Nevi, Spindle Cell
Nevi, Dysplastic
Mucosal Melanoma
Melanoma
Nevus, Blue
Nevus, Pigmented
First Posted Date
2020-04-20
Last Posted Date
2022-06-14
Lead Sponsor
Russian Academy of Medical Sciences
Target Recruit Count
350
Registration Number
NCT04353050
Locations
🇷🇺

Privolzhsky Research Medical University of the Ministry of Health of the Russian Federation, Nizhny Novgorod, Russian Federation

🇷🇺

N.N. Blokhin Russian Cancer Research Center, Moscow, Москва, Russian Federation

Safety and Tolerability of Novel Medical Nutrition Products for NAFLD Treatment

Phase 2
Conditions
NASH - Nonalcoholic Steatohepatitis
NAFLD
First Posted Date
2020-03-16
Last Posted Date
2021-02-03
Lead Sponsor
Russian Academy of Medical Sciences
Target Recruit Count
45
Registration Number
NCT04308980
Locations
🇷🇺

Gastroenterology and Hepatology, FRC Nutrition and Biotechnology, Moscow, Russian Federation

Study of Dietary Patterns and Food Diversity in Russian GERD Patients

Not Applicable
Conditions
Gastroesophageal; Reflux With Esophagitis
Non-erosive Reflux Disease
Gastroesophageal Reflux
Heartburn
GERD
Esophagitis
First Posted Date
2020-02-05
Last Posted Date
2022-02-03
Lead Sponsor
Russian Academy of Medical Sciences
Target Recruit Count
150
Registration Number
NCT04252144
Locations
🇷🇺

Gastroenterology and Hepatology, FRC Nutrition and Biotechnology, Moscow, Russian Federation

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.